Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2024 American Chemical Society
August 19, 2024 Cover
Volume 102, Issue 25
It’s harder than ever to found a chemistry start-up, but young scientists are still taking on the challenge
Cover image:Sudharsan Dwaraknath, Andrew Wang, and Laura Stoy (left to right) all founded companies based on technologies they worked on during a PhD or postdoc. Now, they’re building the skills needed to lead the companies and commercialize their technologies.
Will single-molecule protein sequencing be the next generation of proteomics?
Start-ups have technical challenges to overcome before they can find their place in the market
India seeks a seat at the drug services table
Manufacturers want to replace China as the next destination for making custom pharmaceutical ingredients
-
Can chemical AI help solve the fentanyl crisis?
The technology might thwart illicit production—or it could provide bad actors with untraceable, scalable routes of the synthetic opioid
-
Illicit fentanyl: Still the perfect storm in science
Scientists can help reduce deaths by educating people about the drug’s extreme dangers
-
Researchers link taurine metabolic enzyme to mouse weight
The hydrolase may become a drug target for metabolic syndrome
ADVERTISEMENT
Science Concentrates
- Chemists make the popular fragrance compound ambrox via asymmetric catalysis
- Irish potato famine sparked 180-year evolutionary arms race
- Penguin poo as a source of antibiotic-resistant genes
- Fragment correlation mass spectrometry: a new approach to analyzing tandem mass spectra
- New recipe for green hydrogen mixes aluminum and caffeine in salt water
Researchers link taurine metabolic enzyme to mouse weight
The hydrolase maye becomedrug target for metabolic syndrome
ADVERTISEMENT
EDITORIAL
REACTIONS FROM OUR READERS
ACS Career Tips
ACS NEWS
NEWSCRIPTS
Job listings
- Sichuan University - School of Pharmacy, China: Faculty Recruitment for West China School of Pharmacy, Sichuan University
- Center for Drug Design, University of Minnesota: Postdoctoral Position in Synthetic Medicinal Chemistry
- National Institutes of Health: Director
- Green Bay Packaging, Inc. - Coated Products Operations: Product Development Engineer – Adhesives
